665 related articles for article (PubMed ID: 19129213)
1. Increased Nrf2 activation in livers from Keap1-knockdown mice increases expression of cytoprotective genes that detoxify electrophiles more than those that detoxify reactive oxygen species.
Reisman SA; Yeager RL; Yamamoto M; Klaassen CD
Toxicol Sci; 2009 Mar; 108(1):35-47. PubMed ID: 19129213
[TBL] [Abstract][Full Text] [Related]
2. Altered disposition of acetaminophen in Nrf2-null and Keap1-knockdown mice.
Reisman SA; Csanaky IL; Aleksunes LM; Klaassen CD
Toxicol Sci; 2009 May; 109(1):31-40. PubMed ID: 19246624
[TBL] [Abstract][Full Text] [Related]
3. Nrf2 activation enhances biliary excretion of sulfobromophthalein by inducing glutathione-S-transferase activity.
Reisman SA; Csanaky IL; Yeager RL; Klaassen CD
Toxicol Sci; 2009 May; 109(1):24-30. PubMed ID: 19246623
[TBL] [Abstract][Full Text] [Related]
4. Effect of graded Nrf2 activation on phase-I and -II drug metabolizing enzymes and transporters in mouse liver.
Wu KC; Cui JY; Klaassen CD
PLoS One; 2012; 7(7):e39006. PubMed ID: 22808024
[TBL] [Abstract][Full Text] [Related]
5. The Keap1-Nrf2 system as an in vivo sensor for electrophiles.
Uruno A; Motohashi H
Nitric Oxide; 2011 Aug; 25(2):153-60. PubMed ID: 21385624
[TBL] [Abstract][Full Text] [Related]
6. Nrf2 protects against diquat-induced liver and lung injury.
Wu KC; Zhang Y; Klaassen CD
Free Radic Res; 2012 Oct; 46(10):1220-9. PubMed ID: 22762311
[TBL] [Abstract][Full Text] [Related]
7. Enhanced expression of Nrf2 in mice attenuates the fatty liver produced by a methionine- and choline-deficient diet.
Zhang YK; Yeager RL; Tanaka Y; Klaassen CD
Toxicol Appl Pharmacol; 2010 Jun; 245(3):326-34. PubMed ID: 20350562
[TBL] [Abstract][Full Text] [Related]
8. Nrf2 protects against furosemide-induced hepatotoxicity.
Qu Q; Liu J; Zhou HH; Klaassen CD
Toxicology; 2014 Oct; 324():35-42. PubMed ID: 24813929
[TBL] [Abstract][Full Text] [Related]
9. Nrf2 counteracts cholestatic liver injury via stimulation of hepatic defense systems.
Okada K; Shoda J; Taguchi K; Maher JM; Ishizaki K; Inoue Y; Ohtsuki M; Goto N; Sugimoto H; Utsunomiya H; Oda K; Warabi E; Ishii T; Yamamoto M
Biochem Biophys Res Commun; 2009 Nov; 389(3):431-6. PubMed ID: 19732748
[TBL] [Abstract][Full Text] [Related]
10. Glucose availability is a decisive factor for Nrf2-mediated gene expression.
Heiss EH; Schachner D; Zimmermann K; Dirsch VM
Redox Biol; 2013; 1(1):359-65. PubMed ID: 24024172
[TBL] [Abstract][Full Text] [Related]
11. Role of Nrf2 in preventing ethanol-induced oxidative stress and lipid accumulation.
Wu KC; Liu J; Klaassen CD
Toxicol Appl Pharmacol; 2012 Aug; 262(3):321-9. PubMed ID: 22627062
[TBL] [Abstract][Full Text] [Related]
12. Nrf2 inhibits hepatic iron accumulation and counteracts oxidative stress-induced liver injury in nutritional steatohepatitis.
Okada K; Warabi E; Sugimoto H; Horie M; Tokushige K; Ueda T; Harada N; Taguchi K; Hashimoto E; Itoh K; Ishii T; Utsunomiya H; Yamamoto M; Shoda J
J Gastroenterol; 2012 Aug; 47(8):924-35. PubMed ID: 22367278
[TBL] [Abstract][Full Text] [Related]
13. Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice.
Yates MS; Tran QT; Dolan PM; Osburn WO; Shin S; McCulloch CC; Silkworth JB; Taguchi K; Yamamoto M; Williams CR; Liby KT; Sporn MB; Sutter TR; Kensler TW
Carcinogenesis; 2009 Jun; 30(6):1024-31. PubMed ID: 19386581
[TBL] [Abstract][Full Text] [Related]
14. Ursodeoxycholic acid stimulates Nrf2-mediated hepatocellular transport, detoxification, and antioxidative stress systems in mice.
Okada K; Shoda J; Taguchi K; Maher JM; Ishizaki K; Inoue Y; Ohtsuki M; Goto N; Takeda K; Utsunomiya H; Oda K; Warabi E; Ishii T; Osaka K; Hyodo I; Yamamoto M
Am J Physiol Gastrointest Liver Physiol; 2008 Oct; 295(4):G735-47. PubMed ID: 18687751
[TBL] [Abstract][Full Text] [Related]
15. Keap1/Nrf2 pathway activation leads to a repressed hepatic gluconeogenic and lipogenic program in mice on a high-fat diet.
Slocum SL; Skoko JJ; Wakabayashi N; Aja S; Yamamoto M; Kensler TW; Chartoumpekis DV
Arch Biochem Biophys; 2016 Feb; 591():57-65. PubMed ID: 26701603
[TBL] [Abstract][Full Text] [Related]
16. Keap1 inhibition attenuates glomerulosclerosis.
Miyazaki Y; Shimizu A; Pastan I; Taguchi K; Naganuma E; Suzuki T; Hosoya T; Yokoo T; Saito A; Miyata T; Yamamoto M; Matsusaka T
Nephrol Dial Transplant; 2014 Apr; 29(4):783-91. PubMed ID: 24523358
[TBL] [Abstract][Full Text] [Related]
17. The Keap1/Nrf2 protein axis plays a role in osteoclast differentiation by regulating intracellular reactive oxygen species signaling.
Kanzaki H; Shinohara F; Kajiya M; Kodama T
J Biol Chem; 2013 Aug; 288(32):23009-20. PubMed ID: 23801334
[TBL] [Abstract][Full Text] [Related]
18. Activation of the Nrf2-ARE pathway by siRNA knockdown of Keap1 reduces oxidative stress and provides partial protection from MPTP-mediated neurotoxicity.
Williamson TP; Johnson DA; Johnson JA
Neurotoxicology; 2012 Jun; 33(3):272-9. PubMed ID: 22342405
[TBL] [Abstract][Full Text] [Related]
19. Nuclear factor erythroid-derived factor 2-related factor 2 regulates transcription of CCAAT/enhancer-binding protein β during adipogenesis.
Hou Y; Xue P; Bai Y; Liu D; Woods CG; Yarborough K; Fu J; Zhang Q; Sun G; Collins S; Chan JY; Yamamoto M; Andersen ME; Pi J
Free Radic Biol Med; 2012 Jan; 52(2):462-72. PubMed ID: 22138520
[TBL] [Abstract][Full Text] [Related]
20. Constitutive activation of nuclear factor-E2-related factor 2 induces biotransformation enzyme and transporter expression in livers of mice with hepatocyte-specific deletion of Kelch-like ECH-associated protein 1.
Cheng Q; Taguchi K; Aleksunes LM; Manautou JE; Cherrington NJ; Yamamoto M; Slitt AL
J Biochem Mol Toxicol; 2011; 25(5):320-9. PubMed ID: 21538727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
